首页> 外文OA文献 >Long-term follow-up of 44 patients with adenocarcinoma of the nasal cavity and sinuses primarily treated with endoscopic resection followed by radiotherapy
【2h】

Long-term follow-up of 44 patients with adenocarcinoma of the nasal cavity and sinuses primarily treated with endoscopic resection followed by radiotherapy

机译:鼻内镜下鼻咽癌放疗的鼻腔及鼻窦腺癌44例长期随访

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BACKGROUND: Endoscopic resection followed by radiotherapy as primary treatment for adenocarcinoma of the sinuses is emerging as an alternative to open resection. METHODS: A total of 44 patients primarily treated by an endoscopic approach followed by radiotherapy from 1992 to 2004 seen at our ENT-Department were analyzed for outcome and prognostic factors. RESULTS: Median follow-up was 61 months. Median follow-up of the patients alive at the end of the follow-up period was 100 months. For the 5-year follow-up, the overall survival, disease-specific survival, and recurrence-free survival were 63% (±7% SE), 82% (±6), and 60% (±8%), respectively. The overall survival, disease-specific survival, and recurrence-free survival after 100 months of follow-up were 53% (±8%), 72% (±9%), and 54% (±9%), respectively. Four factors significantly influenced the disease-specific survival. CONCLUSION: This study of a homogeneous cohort of patients with sinonasal adenocarcinoma treated by endoscopic resection and radiotherapy confirms that endoscopic resection is a valid alternative to open resection. © 2010 Wiley Periodicals, Inc. Head Neck, 2010.
机译:背景:内窥镜切除术继之以放射疗法作为鼻窦腺癌的主要治疗方法正在成为开放性切除术的替代方法。方法:分析了1992年至2004年在我们耳鼻喉科就诊的44例主要采用内窥镜治疗及放射治疗的患者的预后和预后因素。结果:中位随访61个月。在随访期结束时,对存活患者的中位随访时间为100个月。在5年的随访中,总生存率,疾病特异性生存率和无复发生存率分别为63%(±7%SE),82%(±6)和60%(±8%)。 。随访100个月后的总生存率,疾病特异性生存率和无复发生存率分别为53%(±8%),72%(±9%)和54%(±9%)。四个因素显着影响特定疾病的生存。结论:这项对内镜下切除和放疗治疗的鼻窦腺癌患者的同类队列的研究证实,内镜下切除术是开放性切除术的有效替代方法。 ©2010 Wiley Periodicals,Inc.头颈,2010年。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号